The Hindu Business Line : Alkem firms up strategy for global foray

Mr B.N. Singh, Managing Director, said the company's strategies ranged from partnering with multinational companies, doing bio-equivalence studies to actually acquiring dossiers on new drug filings in the US market.

Alkem is in talks with an American and Canadian company to work as partners, said Mr Singh. But he was unwilling to divulge more details.

Meanwhile, the company is doing work with the French company Ethypharm for a bio-availability study on the sustained release of Metformin.

At the company's research centre in Taloja, on the outskirts of Mumbai, Mr Singh told mediapersons that the 18-odd month old Phoenix Biopharma Research Centre was doing bio-equivalence studies for several companies. This will be scaled up to doing clinical trials involving human beings, he said.

Company officials said Alkem had done five studies to check the bio-equivalence and bio-availability aspects of drugs. Two of them have been approved by the Drug Controller General of India, Mr Singh said. The company was also receiving enquiries from companies in Europe, he said.

Meanwhile, Alkem is looking to enter the US market either by filing abbreviated new drug applications (ANDA) on its own or by acquiring them from other companies, officials said.

Alkem expects revenue from exports to touch Rs 100 crore by March 2005. It targets revenues of Rs 2 crore from research activities in 2005-06 and about Rs 8 crore in 2007-08, officials said.

To whether the company planned to tap the market to raise funds for its international forays, Mr Singh said there were no immediate plans. He expected to fund the company's plans through internal accruals, besides tapping banks and financial institutions.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Praj Ind develops tech to process sweet sorghum for alcohol production

Panacea Biotech to develop new tech for vaccine storage

Alkem firms up strategy for global foray

Non-audit services issues — `Govt committed to independence of CAs'

`Industry not forthcoming on changes to Arbitration Bill'

Easy exit route for companies sought

Jindal South to buy controlling stake in Siscol

Crisil buys Irevna for Rs 43 cr

Bhilwara group in pact with Norway co for hydro project

Exide to power Afghanistan with its wind, solar energy

Roots Multiclean's new unit

Madurai Aavin staff plea

Maruti tops JD Power survey for fifth year

`We expect earnings to stabilise in next five years'

Official liquidators told to protect properties of cos under their custody

SPIC hopeful of recovery soon

Ford India to break even this year — To roll out new Mondeo in December